Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 3
Submit an article Journal homepage
152
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population

Andrew P. Yu Analysis Group, Inc., Boston, MA, USACorrespondence[email protected]
,
Rym Ben-Hamadi Analysis Group, Inc., Boston, MA, USA
,
Howard G. Birnbaum Analysis Group, Inc., Boston, MA, USA
,
Pavel Atanasov Analysis Group, Inc., Boston, MA, USA
,
Michael D. Stensland Eli Lilly and Company, Indianapolis, IN, USA
&
Glenn Philips Eli Lilly and Company, Indianapolis, IN, USA
Pages 755-764 | Accepted 11 Dec 2008, Published online: 06 Feb 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Thomas R. Einarson, Susana Maia-Lopes, Pushpendra Goswami, Basil G. Bereza & Kristel Van Impe. (2016) Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal. Journal of Medical Economics 19:9, pages 913-921.
Read now
Douglas L Noordsy, Glenn A Phillips, Daniel E Ball & Walter T Linde-Zwirble. (2010) Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia. Patient Preference and Adherence 4, pages 263-271.
Read now
Noam Y. Kirson, Jasmina I. Ivanova, Howard G. Birnbaum, Robert Wei, Evan Kantor, R. Amy Puenpatom, Rami H. Ben-Joseph & Kent H. Summers. (2010) Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%. Journal of Medical Economics 13:3, pages 472-481.
Read now

Articles from other publishers (11)

Amber Martin, Leona Bessonova, Rachel Hughes, Michael J. Doane, Amy K. O’Sullivan, Kassandra Snook, Allie Cichewicz, Peter J. Weiden & Philip D. Harvey. (2022) Systematic Review of Real-World Treatment Patterns of Oral Antipsychotics and Associated Economic Burden in Patients with Schizophrenia in the United States. Advances in Therapy 39:9, pages 3933-3956.
Crossref
Karel Kostev, Galina Osina & Marcel Konrad. (2019) Treatment patterns of patients with schizophrenia based on the data from 44,836 outpatients in Russia. Heart and Mind 3:4, pages 161.
Crossref
Giouliana Kadra, Athan Spiros, Hitesh Shetty, Ehtesham Iqbal, Richard D Hayes, Robert Stewart & Hugo Geerts. (2018) Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare. Journal of Psychopharmacology 32:11, pages 1191-1196.
Crossref
Hugo Geerts, Patrick Roberts, Athan Spiros & Robert Carr. 2016. Systems Pharmacology and Pharmacodynamics. Systems Pharmacology and Pharmacodynamics 305 324 .
Gregory Kruse, Bruce J. O. Wong, Mei Sheng Duh, Patrick Lefebvre, Marie-Hélène Lafeuille & John M. Fastenau. (2015) Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics 33:10, pages 1049-1067.
Crossref
Hugo Geerts & Ludo Kennis. (2014) Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward. Future Medicinal Chemistry 6:16, pages 1757-1769.
Crossref
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe & Masaru Mimura. 2013. Polypharmacy in Psychiatry Practice, Volume II. Polypharmacy in Psychiatry Practice, Volume II 81 107 .
Anand K. Pandurangi & John T. Vernon. 2013. Polypharmacy in Psychiatry Practice, Volume II. Polypharmacy in Psychiatry Practice, Volume II 11 29 .
Jeffrey McCombs, Sara Zolfaghari & Vaidynathan Ganapathy. (2011) Impact of Drug Treatment History on Comparative Effectiveness Research in Schizophrenia. Value in Health 14:5, pages 679-686.
Crossref
Franca Centorrino, Antonio Ventriglio, Alessio Vincenti, Alessandra Talamo & Ross J. Baldessarini. (2010) Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Human Psychopharmacology: Clinical and Experimental 25:2, pages 179-186.
Crossref
Andrew P. Yu, Pavel Atanasov, Rym Ben-Hamadi, Howard Birnbaum, Michael D. Stensland & Glenn Philips. (2009) Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population. Value in Health 12:5, pages 708-715.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.